Items tagged with Drug-resistant TB

Global TB CAB responds to new bedaquiline price (post with simple image)

The TB CAB reiterates its request for Johnson & Johnson to commit to a global price for bedaquiline that is no higher than US$32 per month.

WHO announces landmark changes in MDR-TB treatment regimens (post with simple image)

Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant TB (MDR-TB) are expected.

The TB CAB and TAG welcome WHO recommendation of injectable-free regimens for the treatment of RR/MDR-TB (post with simple image)

The WHO, Ministries of Health and Finance, donors, implementers, technical assistance providers, civil society, and communities must work together to ensure rapid implementation.

Urgent need to register essential medicines for the treatment and prevention of TB in South Africa (post with simple image)

Advocates request that the South African Health Products Regulatory Authority expedite registration of essential medicines for the treatment and prevention of TB in South Africa.

Page 76 of 76 · Total posts: 0

←First 75 76